The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for pemigatinib (Incyte Biosciences Australia Pty Ltd)
Active ingredients
pemigatinib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate-release tablet
Indication
For the treatment of cholangiocarcinoma
Therapeutic area
Oncology